A Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of a New Formulation of Cabotegravir Long-Acting Administered Intramuscularly in a 4-month Dosing Interval (Q4M)

GSK Investigational Site, San Juan

GSK Investigational Site, New York

GSK Investigational Site, Valhalla

GSK Investigational Site, Pittsburgh

GSK Investigational Site, Orlando

GSK Investigational Site, Coral Gables

GSK Investigational Site, West Palm Beach

GSK Investigational Site, Ft. Pierce

GSK Investigational Site, Birmingham

GSK Investigational Site, Columbus

GSK Investigational Site, Cincinnati

GSK Investigational Site, Berkley

GSK Investigational Site, Kansas City

GSK Investigational Site, New Orleans

GSK Investigational Site, Dallas

GSK Investigational Site, Fort Worth

GSK Investigational Site, Las Vegas

GSK Investigational Site, Los Angeles

GSK Investigational Site, Los Angeles

GSK Investigational Site, Los Angeles

GSK Investigational Site, Los Angeles

GSK Investigational Site, Palm Springs

GSK Investigational Site, Seattle

GSK Investigational Site, Chicago

GSK Investigational Site, Springfield

GSK Investigational Site, Greensboro

GSK Investigational Site, San Juan